Non-inferiority study of GSK3511294 compared with mepolizumab or benralizumab in participants with severe asthma with an eosinophilic phenotype (NCT04718389)
NIMBLE
This trial is No longer recruiting
Registration number NCT04718389
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Dr Andrew Gillman
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR